| Literature DB >> 25962319 |
Afonso Nóbrega Dantas1, Everton Freitas de Morais1, Rômulo Augusto de Paiva Macedo1, João Maria de Lima Tinôco2, Maria de Lourdes Silva de Arruda Morais3.
Abstract
INTRODUCTION: Adenoid cystic carcinoma is the most frequent malignant tumor of the submandibular gland and the minor salivary glands. It is a malignant neoplasm that, despite its slow growth, shows an unfavorable prognosis.Entities:
Keywords: Glândulas salivares; Mouth neoplasms; Neoplasias bucais; Neoplasias das glândulas salivares; Salivary gland neoplasms; Salivary glands
Mesh:
Year: 2015 PMID: 25962319 PMCID: PMC9452271 DOI: 10.1016/j.bjorl.2014.07.016
Source DB: PubMed Journal: Braz J Otorhinolaryngol ISSN: 1808-8686
Results obtained by the selected studies.
| Study | Number of patients/gender/age | Location of primary tumor | Metastasis | Treatment | Disease recurrence |
|---|---|---|---|---|---|
| DeAngelis et al. (Australia, 2011) | 24 (7 M/17 F), mean age of 58 years (range 30–81 years). | The palate was the most often affected site, representing 37.5% of cases. | 4.1% had metastases to the cervical lymph nodes and 4.1%, to the cervical spine. | Surgery was performed in 91.6% patients; 87.5% of cases were associated with radiotherapy. Neck dissection was performed in 20.8% of cases. | 25% of the patients had recurrence. |
| Chen AM et al. (USA, 2006) | 140 (81 M/59 F), mean age of 57 years (range 11–91 years). | Parotid (14%); submandibular (18%); sublingual (7%); lacrimal gland (2%); minor salivary glands (24%); oropharynx (9%); hypopharynx (4%); paranasal sinuses (20%); trachea (3%). | 25% of patients had distant metastases. | All patients were treated with definitive surgery. | 16.4% had recurrence. |
| Min et al. (China, 2012) | 616 (302 M/314 F), mean age of 51.6 years (range 11–89 years). | Parotid gland (11%); submandibular gland (13%); sublingual gland (7.5%); hard/soft palate (26.9%); maxillary sinus (9.7%); tongue ventral surface (2.8%); tongue dorsal surface (8.4%); mouth floor (9.6%); oral mucosa (5%); others (6%). | 10.06% of cases had metastases to cervical lymph nodes. | Surgical treatment followed by postoperative radiotherapy was the main option. | Not reported. |
| Luksi et al. (Croatia, 2013) | 26 (12 M/14 F), mean age of 58 (range 34–88) years. | Palate (62%); mouth floor (15%); alveolar mucosa (12%); upper lip (8%); jugal mucosa (4%). | 46.1% had distant metastases. | Surgical treatment followed by postoperative radiotherapy was the main option. | 26.9% had recurrence. |
| Tincani et al. (Brazil, 2006) | 21 (7 M/14 F), aged 26–72 years. | Parotid (19%); submandibular gland (33.3%); palate (47.6%). | 33.3% had regional metastases and 22.2% had distant metastasis. | Surgery was the main treatment with adjuvant radiation therapy in many cases, whereas resection of the structure was necessary in other cases. | 38.09% had recurrence. |
| Bianchi et al. (Italy, 2008) | 67 (28 M/39 F), mean age of 54.5 years (range 28–84 years). | Palate (71.6%); lips (3%); alveolar mucosa (1.5); jugal mucosa (4.5%); retromolar region (4.5%); tongue (4.5%); mouth floor (9%); others (1.5%). | 29.8% of patients had distant metastases. | All patients were treated with surgery as the primary modality. Dissection was performed in 9% of patients, and over half (59.7%) were treated with adjuvant radiation therapy. | 29.8% of patients had recurrence. |
| Perez et al. (Brazil, 2005) | 129 (71 M/58 F), mean age of 51.5 years (range 10–96 years). | Palate (22.5%); tongue (7.7%); jugal mucosa (3.9%); mouth floor (3.9%); upper lip (3.1%); lower lip (0.8%); parotid (19.4%); submandibular (15.5%); sublingual (2.3%); others (20.9%). | 10.07% had regional metastases and 8.5% had distant metastasis. | Patients were treated with local resection associated with postoperative radiotherapy (42.7%), local resection alone (30.2%), or radiotherapy alone (10.1%). Other therapeutic modalities included radiotherapy and chemotherapy (3.9%), local resection and chemotherapy (2.3%), and chemotherapy alone (1.5%). 9.3% of patients received only supportive care. | 55% had local recurrence. |
| Khan et al. (USA, 2001) | 68 (3 0 M/38 F), mean age at diagnosis of 52 years. | The most affected sites were the oropharynx (23.5%), parotid (22.05%), submandibular gland (16.17%). | 10.2% had pulmonary metastasis and 5.8% had lymph node metastasis. | The primary treatment was surgery. 8.8% of patients underwent radiation, 7.3% of patients were poor surgical candidates due to comorbidities, and were treated with curative intent, while 1.4% of patients were treated with palliative care. | 42.6% had recurrence. |
| Sung et al. (Korea, 2003) | 94 (44 M/50 F), age of 44.5 years (range 20–78 years). | The most affected sites were the minor salivary glands (69.1%) and the major salivary glands (30.8%). | 26.5% of patients had distant metastases and 3.1% had regional metastasis. | In cases of patients with distant metastases, 10.6% were treated with surgery, 8.5% with radiotherapy, and 29.7% with both. In patients without distant metastasis, 6.3% were treated with surgery, 7.4% with radiotherapy, and 37.2% with both. | 18.08% had recurrence. |
M, male; F, female.
Tumor characteristics and perineural invasion.
| Study | Size of primary tumor | Histopathological pattern | Perineural invasion | Factors related to perineural invasion |
|---|---|---|---|---|
| DeAngelis et al. (Australia, 2011) | Not mentioned. | Solid (37.5%); tubular or cribriform (54,1%); nonspecific pattern (8.3%). | 62.5% of patients had perineural invasion. | The presence of perineural invasion can result in a high rate of recurrence. |
| Chen et al. (USA, 2006) | Not mentioned. | Not mentioned. | 58.5% of patients had perineural invasion. | Local recurrence was more frequent in patients with perineural invasion. |
| Min et al. (China, 2012) | 75.3% of the patients had primary tumor <3 cm and 24.6% had tumor >3 cm | Solid (38.63%); tubular or cribriform (61.36%). | 52.2% of patients had perineural invasion. | The presence of perineural invasion can result in a high rate of recurrence. |
| Luksi et al. (Croatia, 2013) | Not mentioned. | Not mentioned. | 50% of patients had perineural invasion. | There was no significant association between perineural invasion and the primary tumor size or presence of distant metastases, but there was an association with the local tumor extent. |
| Tincani et al. (Brazil, 2006) | Not mentioned. | Cribriform (38.08%); tubular (38,08%); solid (23.8%). | 42.8% of patients had perineural invasion. | The presence of perineural invasion is closely associated with local tumor recurrence. |
| Bianchi et al. (Italy, 2008) | Tumor size varied between 1 cm and 9 cm. | Solid (46.2%); cribriform (46.2%); tubular (14.9%). | 58.2% of patients had perineural invasion. | The presence of perineural invasion was not associated with the presence of metastasis or the survival rate of the study patients. |
| Perez et al. (Brazil, 2005) | Minor gland tumors had an average size of 4.1 cm, sublingual of 3.8 cm, and parotid of 3.6 cm. | Cribriform (54.2%); tubular (25.2%); solid (20.6%). | 44.9% of patients had perineural invasion. | The presence of perineural invasion was not associated with a negative prognosis. |
| Khan et al. (USA, 2001) | Not mentioned. | 51.4% of patients had predominantly solid tumor. | 29.4% of patients had perineural invasion. | Sinonasal tumors are more likely to show perineural invasion as well as tumors of minor salivary glands. The presence of positive margin was also associated with perineural invasion. |
| Sung et al. (Korea, 2003) | Not mentioned. | Cribriform (32.9%); tubular (20,2%); solid (11.7%). | 30.8% of patients had perineural invasion. | Perineural invasion was not associated with the presence of distant metastases. |